Search research articles
Contact Us
Filters
Showing results (441-450 of 692) with videos related to
Page
of 70
Sort By:
The American Journal of Pathology
|
July 25, 2009
NF-kappaB regulates androgen receptor expression and prostate cancer growth
Liying Zhang, Saleh Altuwaijri, Fangming Deng, et al.
The Journal of Biological Chemistry
|
April 12, 1996
Genistein is a natural inhibitor of hexose and dehydroascorbic acid transport through the glucose transporter, GLUT1
J C Vera, A M Reyes, J G Cárcamo, et al.
Critical Reviews in Oncology/Hematology
|
February 1, 1994
Bladder cancer: advances in biology and treatment
G J Bosl, W R Fair, H W Herr, et al.
Cancer Immunology, Immunotherapy : CII
|
July 11, 2007
A polyvalent vaccine for high-risk prostate patients: "are more antigens better?"
Susan F Slovin, Govind Ragupathi, Celina Fernandez, et al.
The Journal of Urology
|
March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors
H I Scher, A Yagoda, H W Herr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 30, 2010
Portable filter-based microdevice for detection and characterization of circulating tumor cells
Henry K Lin, Siyang Zheng, Anthony J Williams, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T
|
October 1, 2003
Differential Metabolism and Pharmacokinetics of L-[1-(11)C]-Methionine and 2-[(18)F] Fluoro-2-deoxy-D-glucose (FDG) in Androgen Independent Prostate Cancer
Homer A. Macapinlac, John L. Humm, Timothy Akhurst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 29, 2013
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
S F Slovin, C S Higano, O Hamid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 5, 2013
Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy
Timothy J Judson, Antonia V Bennett, Lauren J Rogak, et al.
European Urology
|
December 17, 2016
Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer
Howard I Scher, Ryon P Graf, Nicole A Schreiber, et al.
Page
of 70
Search research articles
Search
Showing results (441-450 of 692) with videos related to
Sort By:
Page
of 70
The American Journal of Pathology
|
July 25, 2009
NF-kappaB regulates androgen receptor expression and prostate cancer growth
Liying Zhang, Saleh Altuwaijri, Fangming Deng, et al.
The Journal of Biological Chemistry
|
April 12, 1996
Genistein is a natural inhibitor of hexose and dehydroascorbic acid transport through the glucose transporter, GLUT1
J C Vera, A M Reyes, J G Cárcamo, et al.
Critical Reviews in Oncology/Hematology
|
February 1, 1994
Bladder cancer: advances in biology and treatment
G J Bosl, W R Fair, H W Herr, et al.
Cancer Immunology, Immunotherapy : CII
|
July 11, 2007
A polyvalent vaccine for high-risk prostate patients: "are more antigens better?"
Susan F Slovin, Govind Ragupathi, Celina Fernandez, et al.
The Journal of Urology
|
March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors
H I Scher, A Yagoda, H W Herr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 30, 2010
Portable filter-based microdevice for detection and characterization of circulating tumor cells
Henry K Lin, Siyang Zheng, Anthony J Williams, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T
|
October 1, 2003
Differential Metabolism and Pharmacokinetics of L-[1-(11)C]-Methionine and 2-[(18)F] Fluoro-2-deoxy-D-glucose (FDG) in Androgen Independent Prostate Cancer
Homer A. Macapinlac, John L. Humm, Timothy Akhurst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 29, 2013
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
S F Slovin, C S Higano, O Hamid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 5, 2013
Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy
Timothy J Judson, Antonia V Bennett, Lauren J Rogak, et al.
European Urology
|
December 17, 2016
Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer
Howard I Scher, Ryon P Graf, Nicole A Schreiber, et al.
Page
of 70